New Indication for Vascepa?



















So as more info comes out from China, Italy, Washington state, and New York where COVID-19 where cardiac experts are coming to believe that the virus can infect the heart muscle. They have even found cardiac damage in 1 in 5 patients leading to heart failure and death in those who show no signs of respiratory distress.
Conditions like pneumonia can cause widespread inflammation in the body. That in turn, can lead to plaque in arteries becoming unstable, causing heart attacks. Inflammation can also cause a condition known as myocarditis, which can lead to the weakening of the heart muscle and, ultimately, heart failure. Doctors are testing new drugs and treatments in clinical trials to ensure that what they have learned about the coronavirus can be shared elsewhere with scientific validity. They have taken patients to the cardiac catheterization lab to clear a suspected blockage , only to find the patient wasn’t really experiencing a heart attack BUT HAD COVID-19!!!!!

I think we all know that Vascepa reduces inflammation and possibly prevent plaque from breaking off!!!

START TESTING VASCEPA IN COVID-19 PATIENTS!!!!

VASCEPA could be one of the miracle drugs in preventing more deaths!

Our CEO, John Thero should look into this! Please!
I am the original poster! Thank you JT for listening to me. Can I now get a promotion?